There was a trend towards increased ACTA2 mRNA levels (the gene encoding α-SMA, a marker of SMC differentiation) in T2DM-SMC although this did not reach statistical significance ( Fig. 1 D).
← all excerpts
Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.
1
—
—